BARCLAYS PLC - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 278 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2021. The put-call ratio across all filers is 1.50 and the average weighting 0.2%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q3 2023$6,355
-3.6%
126,545
+21.3%
0.00%0.0%
Q2 2023$6,594
+44.5%
104,347
+2.9%
0.00%
+100.0%
Q1 2023$4,562
-16.2%
101,400
-18.3%
0.00%0.0%
Q4 2022$5,441
-99.9%
124,186
+68.1%
0.00%
-60.0%
Q3 2022$4,867,000
+279.0%
73,869
+190.4%
0.01%
+400.0%
Q2 2022$1,284,000
-27.8%
25,441
-8.7%
0.00%0.0%
Q1 2022$1,779,000
-88.6%
27,868
-80.8%
0.00%
-66.7%
Q4 2021$15,544,000
+243.1%
145,120
+229.2%
0.00%
+50.0%
Q3 2021$4,531,000
+377.4%
44,079
+307.9%
0.00%
Q2 2021$949,000
-82.5%
10,807
-80.6%
0.00%
-100.0%
Q1 2021$5,412,000
+47.3%
55,668
+69.9%
0.00%
+50.0%
Q4 2020$3,675,000
-1.7%
32,767
-18.7%
0.00%0.0%
Q3 2020$3,739,000
-60.8%
40,307
-67.0%
0.00%
-71.4%
Q2 2020$9,535,000
+184.3%
122,250
+113.2%
0.01%
+133.3%
Q1 2020$3,354,000
-61.4%
57,338
-47.2%
0.00%
-40.0%
Q4 2019$8,694,000
+321.6%
108,528
+286.8%
0.01%
+400.0%
Q3 2019$2,062,000
-70.5%
28,060
-62.2%
0.00%
-75.0%
Q2 2019$6,998,000
+201.6%
74,187
+156.0%
0.00%
+100.0%
Q1 2019$2,320,000
+1181.8%
28,979
+766.9%
0.00%
Q4 2018$181,000
-97.4%
3,343
-96.3%
0.00%
-100.0%
Q3 2018$7,089,000
+457.7%
90,814
+354.0%
0.01%
+500.0%
Q2 2018$1,271,000
+15.0%
20,003
+65.9%
0.00%0.0%
Q1 2018$1,105,000
+58.3%
12,057
+30.4%
0.00%0.0%
Q4 2017$698,000
+243.8%
9,247
+217.1%
0.00%
Q3 2017$203,000
+58.6%
2,916
+15.2%
0.00%
Q2 2017$128,000
-79.3%
2,532
-83.6%
0.00%
-100.0%
Q1 2017$618,000
+653.7%
15,455
+431.5%
0.00%
Q4 2016$82,000
+1071.4%
2,908
+1096.7%
0.00%
Q3 2016$7,0000.0%243
-26.4%
0.00%
Q2 2016$7,000
+250.0%
330
+153.8%
0.00%
Q1 2016$2,000
-83.3%
130
-73.0%
0.00%
Q4 2015$12,000
-14.3%
482
-28.4%
0.00%
Q3 2015$14,000
-33.3%
673
-16.3%
0.00%
Q2 2015$21,0008040.00%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q2 2021
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 581,768$25,487,2569.57%
Casdin Capital, LLC 1,477,800$64,742,4185.02%
Nextech Invest Ltd. 188,228$8,246,2693.28%
DAFNA Capital Management LLC 261,235$11,444,7053.22%
Rock Springs Capital Management LP 1,891,510$82,867,0531.99%
HealthCor Management, L.P. 30,000$1,314,3001.20%
EFG Asset Management (North America) Corp. 110,853$4,766,6791.07%
Novo Holdings A/S 370,000$16,209,7001.01%
SECTORAL ASSET MANAGEMENT INC 115,900$5,077,5790.98%
EMERALD MUTUAL FUND ADVISERS TRUST 305,709$13,393,1110.83%
View complete list of BLUEPRINT MEDICINES CORP shareholders